MOLECULAR DOCKING STUDIES AND BIOACTIVITY OF VARIOUS BENZILIC ACIDS AND ITS ANALOGS
Objective: Various benzilic acids and its analogs have been synthesized using the protocol, obtain good to exceptional yield and their biological activity, and its docking studies have been discussed.
Methods: Molecular docking studies were performed by discovery studio - LibDock docking program. To determine the cytotoxic effects, we used an MTT viability assay.
Results: The results showed that cell growth is significantly lower in extract treated cells compared to untreated control. The effect of inhibition of cell growth was shown in different concentration dosages for cytotoxic, antibacterial, and antioxidant activity in vitro.
Conclusion: From the antibacterial results prove that the synthesized compounds showed the potential activity. These remarks may give the encouragement of further development of our research in this field. The antioxidant activity was also performed for the compound benzilic acid and its substituted analogs.
2. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
3. Grivennikov SI, Karin M. Inflammation and oncogenesis: A vicious connection. Curr Opin Genet Dev 2010;20:65-71.
4. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
5. Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 2007;26:525-34.
6. Niki E. Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products? FEBS Lett 2012;586:3767-70.
7. Foucault C, Brouqui P. How to fight antimicrobial resistance. FEMS Immunol Med Microbiol 2007;49:173-83.
8. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-73.
9. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, et al. Antimicrobial resistance. Is a major threat to public health. BMJ 1998;317:609-10.
10. Travis J. Reviving the antibiotic miracle? Science 1994;264:360-2.
11. Hata K, Hata J, Miki HT, Toyosawa T, Nakamura T, Katsu K. In-vitro and in-vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agents Chemother 1996;40:2237-42.
12. Sugawara T, Shibazaki M, Nakahara H, Suzuki K. YM-47522, a novel antifungal antibiotic produced by Bacillus sp. II, Structure and relative stereochemistry. J Antibiot (Tokyo) 1996;49:345-8.
13. Moellering RC Jr. Vancomycin-resistant enterococci. Clin Infect Dis 1998;26:1196-9.
14. Davies J, Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264:375-82.
15. Thomson JM, Bonomo RA. The threat of antibiotic resistance in gram-negative pathogenic bacteria: Beta-lactams in peril! Curr Opin Microbiol 2005;8:518-24.
16. Evangeline RM, Murugan N, Kumar PP. In vitro studies on Î±-glucosidase inhibition, antioxidant and free radical scavenging properties of tecoma stans. Int J Pharm Pharm Sci 2015;7:44-9.
17. Sudha R, Kanakam CC, Nithya G. Synthesis characteraisation and antimicrobial activity of substituted benzilic acids. Int J ChemTech Res 2015;8:383-7.
18. Sudha R, Kanakam CC, Nithya G. In vitro antioxidant activity of different substituted benzilic acid using 2,2-Diphenyl-1-Picryl hydrazyl radical, ABTS assay method. Asian J Pharm Clin Res 2016;9:127-30.
19. Sudha R, Devi B, Kanakam CC, Nithya G. Docking studies for various anti-bacterial benzilate derivatives. Asian J Pharm Clin Res 2017;10:268-71.
20. Sudha R, Kanakam CC, Nithya G, Devi B. Docking anti-oxidant activity on hydroxyl (diphenyl) acetic acid and its derivatives. Asian J Pharm Clin Res 2017;10:263-5.
21. Aniyery RB, Gupta A, Singh P , Sanju. In vitro and in silico antimicrobial study of stannane of pyridoxal 5-phosphate. J Chem Pharm Sci;2017;247:142.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.